Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94


Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.

Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ.

Clin Cancer Res. 2006 Oct 1;12(19):5705-12.


Gene expression signature predicts recurrence in lung adenocarcinoma.

Larsen JE, Pavey SJ, Passmore LH, Bowman RV, Hayward NK, Fong KM.

Clin Cancer Res. 2007 May 15;13(10):2946-54.


Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

Sotiriou C, Wirapati P, Loi S, Harris A, Fox S, Smeds J, Nordgren H, Farmer P, Praz V, Haibe-Kains B, Desmedt C, Larsimont D, Cardoso F, Peterse H, Nuyten D, Buyse M, Van de Vijver MJ, Bergh J, Piccart M, Delorenzi M.

J Natl Cancer Inst. 2006 Feb 15;98(4):262-72.


Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.

Wang Y, Jatkoe T, Zhang Y, Mutch MG, Talantov D, Jiang J, McLeod HL, Atkins D.

J Clin Oncol. 2004 May 1;22(9):1564-71. Epub 2004 Mar 29.


Population-based molecular prognosis of breast cancer by transcriptional profiling.

Ma Y, Qian Y, Wei L, Abraham J, Shi X, Castranova V, Harner EJ, Flynn DC, Guo L.

Clin Cancer Res. 2007 Apr 1;13(7):2014-22.


Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma.

Pijnenborg JM, Romano A, Dam-de Veen GC, Dunselman GA, Fischer DC, Groothuis PG, Kieback DG.

J Pathol. 2005 Apr;205(5):597-605.


Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression.

Lee ES, Son DS, Kim SH, Lee J, Jo J, Han J, Kim H, Lee HJ, Choi HY, Jung Y, Park M, Lim YS, Kim K, Shim Y, Kim BC, Lee K, Huh N, Ko C, Park K, Lee JW, Choi YS, Kim J.

Clin Cancer Res. 2008 Nov 15;14(22):7397-404. doi: 10.1158/1078-0432.CCR-07-4937.


Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.

Oberthuer A, Berthold F, Warnat P, Hero B, Kahlert Y, Spitz R, Ernestus K, König R, Haas S, Eils R, Schwab M, Brors B, Westermann F, Fischer M.

J Clin Oncol. 2006 Nov 1;24(31):5070-8.


HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients.

Morrison C, Zanagnolo V, Ramirez N, Cohn DE, Kelbick N, Copeland L, Maxwell GL, Fowler JM.

J Clin Oncol. 2006 May 20;24(15):2376-85. Erratum in: J Clin Oncol. 2006 Jul 20;24(21):3515. Maxwell, Larry G [corrected to Maxwell, G Larry].


Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients.

Yang SH, Seo MY, Jeong HJ, Jeung HC, Shin J, Kim SC, Noh SH, Chung HC, Rha SY.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):612-20.


Gene expression profiling in human endometrial cancer tissue samples: utility and diagnostic value.

Smid-Koopman E, Blok LJ, Helmerhorst TJ, Chadha-Ajwani S, Burger CW, Brinkmann AO, Huikeshoven FJ.

Gynecol Oncol. 2004 May;93(2):292-300.


Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.

Cordes C, Bartling B, Simm A, Afar D, Lautenschläger C, Hansen G, Silber RE, Burdach S, Hofmann HS.

Lung Cancer. 2009 Apr;64(1):79-85. doi: 10.1016/j.lungcan.2008.07.005. Epub 2008 Aug 29.


Prediction of lymphatic invasion/lymph node metastasis, recurrence, and survival in patients with gastric cancer by cDNA array-based expression profiling.

Teramoto K, Tada M, Tamoto E, Abe M, Kawakami A, Komuro K, Matsunaga A, Shindoh G, Takada M, Murakawa K, Kanai M, Kobayashi N, Fujiwara Y, Nishimura N, Shirata K, Takahishi T, Ishizu A, Ikeda H, Hamada J, Kondo S, Katoh H, Moriuchi T, Yoshiki T.

J Surg Res. 2005 Apr;124(2):225-36.


Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.

Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, Kim W, Park SC, Chung YJ, Kim BG, Yoon JH, Lee HS, Kim CY, Yi NJ, Suh KS, Lee KU, Chu IS, Roskams T, Thorgeirsson SS, Kim YJ.

Clin Cancer Res. 2008 Apr 1;14(7):2056-64. doi: 10.1158/1078-0432.CCR-07-1473.


Outcome of patients with stage II and III nonseminomatous germ cell tumors: results of a single center.

Ataergin S, Ozet A, Arpaci F, Kilic S, Beyzadeoglu M, Komurcu S.

Indian J Cancer. 2007 Jan-Mar;44(1):6-11.


Comparison of the molecular classification with FIGO stage and histological grade on endometrial cancer.

Cai B, Liu L, Xi W, Zhu YP, Lu GZ, Yang YX, Wan XP.

Eur J Gynaecol Oncol. 2007;28(6):451-60.


Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.


Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer.

Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, Salovaara R, Nicorici D, Hautaniemi S, Alazzouzi H, Mecklin JP, Järvinen H, Hemminki A, Astola J, Schwartz S Jr, Aaltonen LA.

Gastroenterology. 2005 Sep;129(3):874-84.


Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.

Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47.


Supplemental Content

Support Center